Product Information
VERAPAMIL ER PM 100 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $4.0168 per EA under NDC 52536048537. Its NADAC has been published 46 times since Oct 8, 2025.
FDA first approved this application on Nov 25, 1998.
Strength
100 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536048537
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020943FDA Approved
11/25/1998
On Market Since
11/26/2024
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER PM 100 MG CAPSULE has been published 46 times since Oct 8, 2025, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0168 per EA |
|---|---|
| All-time high | $4.4528 (Nov 12, 2025) |
| All-time low | $3.9312 (Nov 19, 2025) |
| 52-week high | $4.4528 |
| 52-week low | $3.9312 |
| Median price | $4.0663 |
| Average price | $4.0872 |
| Largest weekly change | -11.7% (Nov 19, 2025) |
| Weeks tracked | 46 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL ER PM 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER PM 100 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $4.0168 per EA (NDC 52536048537), effective Aug 19, 2026.
How has the price of VERAPAMIL ER PM 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER PM 100 MG CAPSULE has declined 9.8%. It has been tracked across 46 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER PM 100 MG CAPSULE?
Since Oct 8, 2025, the NADAC for VERAPAMIL ER PM 100 MG CAPSULE has ranged from a low of $3.9312 (Nov 19, 2025) to a high of $4.4528 (Nov 12, 2025), with a median of $4.0663 per EA.
Are there cheaper alternatives to VERAPAMIL ER PM 100 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VERAPAMIL ER PM 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL ER PM 100 MG CAPSULE?
VERAPAMIL ER PM 100 MG CAPSULE (NDC 52536048537) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.